ArticleZeitschrift fur Rheumatologie2018

[Efficacy and safety analysis of off-label treatment with biologics in autoinflammatory diseases : Experiences from a German registry (GRAID2)].

F Proft et al.PubMed ↗Publisher ↗

No numbers read from the abstract.